Results 101 to 110 of about 1,157 (167)

Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan

open access: yesJournal of Blood Medicine, 2019
Imran Moinuddin, Craig Fletcher, Peter MillwardDepartment of Pathology and Laboratory Medicine, Beaumont Hospital, Royal Oak, MI 48073, USACorrespondence: Imran MoinuddinDepartment of Pathology and Laboratory Medicine, Beaumont Hospital, 9190 Springfield
Moinuddin I, Fletcher C, Millward P
doaj  

Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study. [PDF]

open access: yesJMIR Pediatr Parent
Khadka N   +9 more
europepmc   +1 more source

Characterization of the clinical course of early-onset severe hemolytic disease of the fetus and newborn. [PDF]

open access: yesPregnancy (Hoboken)
Oepkes D   +20 more
europepmc   +1 more source

Plain Language Summary of Publication: Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). [PDF]

open access: yesAm J Perinatol
Tjoa ML   +8 more
europepmc   +1 more source

Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). [PDF]

open access: yesAm J Perinatol
Tjoa ML   +8 more
europepmc   +1 more source

Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study. [PDF]

open access: yesAJOG Glob Rep
Desalew A   +9 more
europepmc   +1 more source

Society for Maternal-Fetal Medicine Statement: Evaluation and management of cell-free DNA screening for fetal red cell antigen genotype in alloimmunized and non-alloimmunized pregnancies. [PDF]

open access: yesPregnancy (Hoboken)
Society for Maternal‐Fetal Medicine (SMFM)   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy